Condition
Ovarian Hyperstimulation
Total Trials
6
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
16.7%
1 terminated out of 6 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results75% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 1 (1)
P 2 (1)
P 3 (1)
P 4 (1)
Trial Status
Completed3
Unknown2
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04002141Phase 2Completed
Assessment and Prevention of Pain During Ovarian Stimulation in Patients With Endometriosis
NCT02715336Phase 4Unknown
Efficacy and Safety of Medication Used to Stimulate Ovulation
NCT04175990Phase 1Completed
IVF Outcome Following Progestogen Ovarian Stimulation
NCT03473613Phase 3CompletedPrimary
Cabergoline Versus Calcium Infusion in Ovarian Hyperstimulation Syndrome Prevention
NCT02975713TerminatedPrimary
Progesterone Diurnal Rhythm During Ovarian Stimulation for IVF
NCT02416596Not ApplicableUnknown
Routine Hysteroscopy in IVF/ICSI Cycles in Patients With Primary Unexplained Infertility
Showing all 6 trials